000			01833 a2200505 4500
005			20250514052301.0
264		0	_c20030114
008			200301s 0 0 eng d
022			_a0165-5728
024	7		_a10.1016/s0165-5728(02)00365-x _2doi
040			_aNLM _beng _cNLM
100	1		_aJiang, Xiuju
245	0	0	_aVIP and PACAP down-regulate CXCL10 (IP-10) and up-regulate CCL22 (MDC) in spleen cells. _h[electronic resource]
260			_bJournal of neuroimmunology _cDec 2002
300			_a81-94 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aChemokine CCL22
650	0	4	_aChemokine CXCL10
650	0	4	_aChemokines, CC _ximmunology
650	0	4	_aChemokines, CXC _xgenetics
650	0	4	_aChemotaxis, Leukocyte _xdrug effects
650	0	4	_aDendritic Cells _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aNeuropeptides _ximmunology
650	0	4	_aPituitary Adenylate Cyclase-Activating Polypeptide
650	0	4	_aRNA, Messenger _xdrug effects
650	0	4	_aReceptors, Cell Surface _xdrug effects
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSpleen _xcytology
650	0	4	_aTh1 Cells _xdrug effects
650	0	4	_aTh2 Cells _xdrug effects
650	0	4	_aUp-Regulation _xdrug effects
650	0	4	_aVasoactive Intestinal Peptide _ximmunology
700	1		_aJing, Huie
700	1		_aGanea, Doina
773	0		_tJournal of neuroimmunology _gvol. 133 _gno. 1-2 _gp. 81-94
856	4	0	_uhttps://doi.org/10.1016/s0165-5728(02)00365-x _zAvailable from publisher's website
999			_c12252455 _d12252455